1305P Health-related quality of life (HRQoL) in a phase III study of first-line brigatinib (BRG) vs crizotinib (CRZ) in NSCLC: Updated results from ALTA-1L
Keyword(s):
Keyword(s):
2011 ◽
Vol 6
(11)
◽
pp. 1872-1880
◽
Keyword(s):
2015 ◽
Vol 51
(7)
◽
pp. 833-840
◽
Keyword(s):
2008 ◽
Vol 6
(1)
◽
pp. 75
◽
Keyword(s):
2013 ◽
Vol 28
(6)
◽
pp. 790-798
◽
Keyword(s):
1999 ◽
Vol 35
◽
pp. S318
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):